INBS Q1 2025 Earnings WiderThanExpected Loss as Revenue Remains Absent Ernexa Therapeutics Inc ERNA Q3 2023 Earnings Narrowing Losses Amidst Pipeline Progress Precipio Inc PRPO Q2 2025 Earnings Unexpected Profitability Amid Revenue Challenges GPCR Q1 2026 Earnings Smaller Loss Than Expected as Pipeline Advances Lexeo Therapeutics Q1 2026 Earnings EPS Beat on Lower Operating Costs BRC Q1 2026 Earnings Strong EPS Beat Drives Stock Higher